Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Newsol Technologies is a Canadian healthcare device company focused on peritoneal dialysis systems for the treatment of end-stage renal disease. The company develops and seeks to commercialize the SmartPD system, a portable, computerized automated peritoneal dialysis platform with associated disposable accessories and data management capabilities. Its technology is designed for use in clinics, hospitals, and especially home-care settings, with an emphasis on improving treatment efficiency, patient quality of life, and dialysis economics. Newsol positions itself as a specialist in peritoneal dialysis rather than drug development, and its intellectual property estate includes multiple patents related to peritoneal dialysis systems and methods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Newsol Technologies.